Pathkey.AI (ASX:PKY) in Focus as Former Altium Chairman Joins Chipforge Strategy

Aditi Sarkar

12 August 2026 11:25 AM AEST

Pathkey.AI (ASX:PKY) in Focus as Former Altium Chairman Joins Chipforge Strategy

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Pathkey.AI Ltd (ASX:PKY) traded at AUD 0.040, up 29.03% during the morning session on 12 August 2026, and remains up 100.00% over the past year.
The company appointed former Altium Limited Chairman Sam Weiss as a strategic advisor to support the CEO and Chipforge team.
Pathkey.AI secured firm commitments for a $2.8 million strategic Placement at $0.028 per share.
Placement proceeds will support Chipforge technology development, marketing, Business development programs and working capital.
Sam Weiss previously served as Non-Executive Chairman of Altium Limited from 2007 to 2024.

Pathkey.AI Ltd (ASX:PKY) was trading at AUD 0.040, up 29.03% during the morning Trading session on 12 August 2026, with the company’s shares remaining up 100.00% over the past year. The company has announced the appointment of former Altium Limited Chairman Sam Weiss as a strategic advisor, alongside a $2.8 million strategic placement aimed at supporting the development of its artificial intelligence technology platforms.

Pathkey.AI is an Australian technology company developing artificial intelligence-powered large language model solutions for data-intensive industries. Its platforms include TrialKey, focused on clinical trial design and optimisation, and Chipforge, an AI-powered chip design platform targeting semiconductor engineering workflows.

Strategic Advisor Appointment Brings Altium Experience to Chipforge

Pathkey.AI has appointed Sam Weiss as a strategic advisor to Chief Executive Officer and the Chipforge team. Weiss served as Non-Executive Chairman of ASX-listed Altium Limited from 2007 to 2024.

During his tenure at Altium, Weiss oversaw the company’s development from a Sydney-based software business into a global provider of printed circuit board design software. His chairmanship concluded with the Acquisition of Altium by Japanese semiconductor company Renesas Electronics for approximately A$9.1 billion in cash.

Pathkey.AI stated that Chipforge operates in the semiconductor design market, applying artificial intelligence-based automation to FPGA and ASIC workflows. The company highlighted similarities between the convergence of design software and silicon markets and the technology area targeted by Chipforge.

$2.8 Million Placement to Fund Technology and Commercial Programs

Alongside the advisor appointment, Pathkey.AI announced firm commitments to raise $2.8 million before costs through a strategic placement to institutional and sophisticated investors.

The placement was cornerstoned by Sam Weiss, with 100 million new fully paid ordinary shares to be issued at $0.028 per share. Settlement of the placement shares is expected on 19 August 2026, with allotment anticipated on or around 20 August 2026.

As part of Weiss’ engagement, Pathkey.AI will issue 40 million performance rights under the company’s incentive plan. The performance rights will vest in equal tranches after 6, 12, 24 and 36 months of service.

The securities will be issued under Pathkey.AI’s existing placement capacity available under ASX Listing Rules 7.1 and 7.1A.

Funding Allocation Across Chipforge and Existing Assets

Pathkey.AI plans to use the placement proceeds to accelerate technology development, Marketing and business development activities for Chipforge. Funds will also support business development programs associated with existing assets, commercial initiatives and general Working Capital requirements.

The company said the capital raising will support its broader growth objectives across its artificial intelligence platforms.

The placement is being managed by Blue Ocean Equities Pty Ltd, 708 Capital Pty Limited and Sandton Capital Pty Limited, which are acting as joint lead managers. The lead managers are entitled to receive a 6% fee on funds raised.

Blue Ocean Equities will also act as book runner and receive 10 million unlisted options with an exercise price of $0.05, expiring on 17 December 2027, for its role in managing the placement.

Chipforge Targets AI-Based Semiconductor Design Workflows

Chipforge is being developed as an AI-native chip design and verification platform covering FPGA and ASIC targets. According to Pathkey.AI, the platform is designed to provide an end-to-end workflow from design intent through generated register transfer level code, verification, simulation and sign-off.

Chipforge Pte. Ltd., incorporated in Singapore, forms part of the Pathkey.AI group.

The company describes both Chipforge and TrialKey as being built around an agent-based AI architecture that combines large language model functionality with neuro-symbolic reasoning. The platforms use AI agents to generate candidate solutions, assess them against defined objectives and refine outcomes through reinforcement-driven optimisation.

Investor Takeaway

Pathkey.AI’s latest update combines a strategic advisor appointment with a capital raising aimed at supporting development of its AI technology platforms. The appointment of Sam Weiss adds experience from his tenure at Altium Limited, while the $2.8 million placement provides funding allocated towards Chipforge development, marketing, commercial initiatives and working capital. Investors may continue watching the progress of Chipforge, business development programs and the company’s broader execution of its artificial intelligence platform strategy.

FAQs

Q: Who has Pathkey.AI appointed as a strategic advisor?

A: Pathkey.AI appointed Sam Weiss, the former Non-Executive Chairman of Altium Limited, as a strategic advisor to the CEO and Chipforge team.

Q: How much capital did Pathkey.AI raise through the placement?

A: Pathkey.AI secured commitments to raise $2.8 million before costs through a strategic placement.

Q: What is Chipforge developing?

A: Chipforge is developing an AI-native chip design and verification platform covering FPGA and ASIC targets.

Q: How will Pathkey.AI use the placement proceeds?

A: Funds will be used for Chipforge technology development, marketing, business development, existing asset programs, commercial initiatives and general working capital.

Q: When are the placement shares expected to be issued?

A: The placement shares are expected to settle on 19 August 2026 and be allotted on or around 20 August 2026.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.